Clinical trials
Paresthesia trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
64 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2002 | 1 |
| 2003 | 1 |
| 2005 | 3 |
| 2007 | 2 |
| 2010 | 1 |
| 2011 | 4 |
| 2012 | 3 |
| 2013 | 1 |
| 2014 | 2 |
| 2015 | 3 |
| 2016 | 5 |
| 2017 | 3 |
| 2019 | 1 |
| 2020 | 4 |
| 2021 | 2 |
| 2022 | 3 |
| 2023 | 6 |
| 2024 | 6 |
| 2025 | 8 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 41 |
| Unknown status | 8 |
| Recruiting | 7 |
| Not yet recruiting | 3 |
| Withdrawn | 2 |
| Terminated | 1 |
| Suspended | 1 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Bernardino Clavo, MD, PhD | 2 |
| Centre Hospitalier Régional Metz-Thionville | 2 |
| Maastricht University Medical Center | 2 |
| Marmara University | 2 |
| Mayo Clinic | 2 |
| Rigshospitalet, Denmark | 2 |
| Sanofi | 2 |
| Altamash Institute of Dental Medicine | 1 |
| Ankara City Hospital Bilkent | 1 |
| Assiut University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Paresthesia | 64 |
| Pain | 14 |
| Hypesthesia | 13 |
| Carpal Tunnel Syndrome | 4 |
| Peripheral Nervous System Diseases | 4 |
| Hyperalgesia | 3 |
| Muscle Weakness | 3 |
| Neoplasm Metastasis | 3 |
| Neuralgia | 3 |
| Neurotoxicity Syndromes | 3 |
Trials
Showing 26 to 50 of 64. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.